Article

COVID-19 and Inflammatory Bowel Diseases: risk assessment, shared molecular pathways and therapeutic challenges

2020-05-01

Abstract excerpt

<h4>Background</h4> The novel coronavirus SARS-CoV-2 causing COVID-19 disease is yielding a global outbreak with serious threats to public health. In this paper, we aimed to review the current knowledge about COVID-19 infectious risk status in inflammatory bowel disease (IBD) patients requiring immunosuppressive medication. Also, we focused on several molecular insights that could explain why IBD patients appear t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5694090a-11a1-5ba6-9ae7-4b147cc308bf
DOI: 10.1101/2020.04.28.20082859

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 and Inflammatory Bowel Diseases: risk assessment, shared molecular pathways and therapeutic challengesDOI 10.1101/2020.04.28.20082859Read

Reduced SARS-CoV-2 infection levels and pathotype specific altered antiviral transcriptional response in IBD intestinal organoidsSemantic proximity Read

Reduced SARS-CoV-2 infection and altered antiviral transcriptional response in IBD intestinal organoidsSemantic proximity Read

Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related diseaseSemantic proximity Read

Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue is downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colonSemantic proximity Read

Inflammatory bowel disease and risk of more than 1500 comorbidities: A disease-wide pre- and post-diagnostic phenomic association studySemantic proximity Read

New insights on the pathomechanisms of inflammatory bowel disease.Semantic proximity Read

Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?Semantic proximity Read

Seroprevalence of Anti-Sars-CoV-2 Antibodies in Patients with Inflammatory Bowel DiseaseSemantic proximity Read

Alimentary System is Directly Attacked by SARS-COV-2 and Further Prevents Immune Dysregulation Caused by COVID-19Semantic proximity Read

A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19Semantic proximity Read

Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseasesSemantic proximity Read

Molecular diagnosis and classification of inflammatory bowel disease.Semantic proximity Read